IDSIQ
Registro de marca em vigor (Madri)
Marca Nominativa depositada no INPI em
30/12/2020 por Idorsia Pharmaceuticals Ltd,
processo nº 501584862, nas classes 09, 16, 41, 42.
Registro em vigor até 30/12/2030.
| Número do processo | 501584862 |
|---|
| Situação | Registro de marca em vigor (Madri) |
|---|
| Apresentação | Nominativa |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 30/12/2020 |
|---|
| Data da concessão | 17/05/2022 |
|---|
| Vigência até | 30/12/2030 |
|---|
| Titular | Idorsia Pharmaceuticals Ltd |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · CH |
Classes e especificação
Electronic publications (downloadable) in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients.;
Printed matter (publications) in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients.;
Multimedia publication of printed matter in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients.;
Scientific research and development, namely pharmaceutical and medical testing services and development of pharmaceutical and medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration.;